Literature DB >> 2479347

Clinical features of aortic arch anomaly with malalignment ventricular septal defect.

M Iwahara1, T Ino, K Nishimoto, I Park, K Akimoto, S Shimazaki, K Yabuta, A Tanaka, Y Hosoda.   

Abstract

The clinical features and outcome after various surgical procedures on 9 patients with coarctation or interruption of the aortic arch and malalignment ventricular septal defect (group 1) were compared with those of 9 patients with the arch anomaly without malalignment ventricular septal defect (group 2). Cardiomegaly and metabolic acidosis were prominent in group 1. Five of the 9 patients in group 1 died in the immediate postoperative period (56% mortality), but no operative deaths occurred among 8 patients in group 2 (p less than 0.01). The ratio of left ventricular outflow tract to ascending aortic diameter was 0.59 +/- 0.09 in group 1 and 1.03 +/- 0.11 in group 2 (p less than 0.01). Three of 4 patients with a ratio of less than 0.6 died, but no operative deaths occurred among the 6 patients who had a palliative operation and in whom the ratio was more than 0.6. These data suggest that left ventricular outflow tract obstruction is critical when the ratio of left ventricular outflow tract to ascending aortic diameter is 0.6 or less. The presence of severe left ventricular outflow tract obstruction necessitates modification of the present surgical strategy.

Entities:  

Mesh:

Year:  1989        PMID: 2479347     DOI: 10.1016/0003-4975(89)90794-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Morphology of left ventricular outflow tract structures in patients with subaortic stenosis and a ventricular septal defect.

Authors:  D Kitchiner; M Jackson; N Malaiya; K Walsh; I Peart; R Arnold; A Smith
Journal:  Br Heart J       Date:  1994-09

2.  Posterior deviation of left ventricular outflow tract septal components without ventricular septal defect.

Authors:  S Ozkutlu; N K Tokel; M Saraçlar; D Alehan; Y Yurdakul; S Ruacan
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.